Company Filing History:
2 out of 37 
1 out of 5 
1 out of 19 Years Active: 1993-1999
Title: Shigeyuki Kawa: Innovator in Tumor Cell Research
Introduction
Shigeyuki Kawa is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of cancer research, particularly in the area of tumor cell motility and inflammation. With a total of 4 patents to his name, Kawa's work has the potential to impact therapeutic strategies for cancer treatment.
Latest Patents
Kawa's latest patents include innovative methods for inhibiting cell motility by utilizing sphingosine-1-phosphate. His patents describe various methods aimed at inhibiting tumor cell chemotactic motility and chemoinvasion. Additionally, he has developed methods to inhibit the phagokinetic activity of tumor cells and neutrophils, as well as strategies to prevent tumor cell metastasis. His work also addresses inflammation caused by the motility and invasion of neutrophils into blood vessel walls, emphasizing the use of sphingosine-1-phosphate and its derivatives as therapeutic agents.
Career Highlights
Throughout his career, Kawa has worked with notable organizations such as the Biomembrane Institute and Oncomembrane, Inc. His research has focused on the development of methods that leverage sphingosine-1-phosphate to combat cancer-related challenges. Kawa's innovative approaches have positioned him as a key figure in the ongoing fight against cancer.
Collaborations
Kawa has collaborated with esteemed colleagues, including Yasuyuki Igarashi and Yoshito Sadahira. These partnerships have further enriched his research and contributed to the advancement of cancer therapies.
Conclusion
Shigeyuki Kawa's contributions to cancer research through his innovative patents highlight his dedication to improving treatment options for patients. His work continues to inspire advancements in the field of oncology.